BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Context Capital Management, LLC's Holding History (CIK: 0001301396)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 79,754,000 Value ($000) $89,823 Avg Close — Range —
Q3 2025
Shares 97,854 Value ($000) $96,704 Avg Close — Range —
Q2 2025
Shares 72,704 Value ($000) $68,051 Avg Close — Range —
Q1 2025
Shares 70,404 Value ($000) $63,469 Avg Close — Range —
Q4 2024
Shares 68,904 Value ($000) $59,120 Avg Close — Range —
Q3 2024
Shares 61,339 Value ($000) $51,525 Avg Close — Range —
Q2 2024
Shares 48,339 Value ($000) $38,519 Avg Close — Range —
Q1 2024
Shares 36,289 Value ($000) $29,904 Avg Close — Range —
Q4 2023
Shares 25,083,000 Value ($000) $21,368 Avg Close — Range —
Q3 2023
Shares 32,083 Value ($000) $24 Avg Close — Range —
Q2 2023
Shares 33,683 Value ($000) $21 Avg Close — Range —
Q1 2023
Shares 26,583 Value ($000) $17 Avg Close — Range —
Q4 2022
Shares 16,458 Value ($000) $6 Avg Close — Range —
Q3 2022
Shares 16,458 Value ($000) $7,365 Avg Close — Range —
Q2 2022
Shares 16,458 Value ($000) $6,726 Avg Close — Range —
Q1 2022
Shares 22,958 Value ($000) $11,209 Avg Close — Range —